Rhythmic Risk of Type 1 Brugada Syndrome and Pulmonary Infundibulum Mapping (SB-CARTO)
Status
Conditions
Treatments
Details and patient eligibility
About
Brugada syndrome has been described as the association of a right bundle block with ST segment elevation on the V1 to V3 electrocardiogram in patients with a structurally normal heart. The rhythmic risk is thus difficult to evaluate in asymptomatic patients in whom the rate of events is estimated at 0.2 to 1.4% of events per year. In addition, the predictive value of ventricular pacing remains controversial; There is therefore currently no review to effectively assess rhythmic risk in patients with Brugada type I syndrome.
Investigators aimed to show a difference in pulmonary infundibulum voltage mapping in symptomatic and asymptomatic patients with Brugada type 1 syndrome with a comparable ECG.
The mapping of the pulmonary infundibulum will be performed during electrophysiological exploration. Only the catheter used differs from the usual procedure.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Group 21
- Brugada Type 1 syndrome
- Age : 50-60 years old
- Asymptomatic
- Signed informed consent
Group2
- Brugada Type 1 syndrome
- Age >18 years old
- Implantable defibrillator
- Having received at least 1 appropriate shock or a sudden sudden death
- Signed informed consent
Groups 1 and 2
Exclusion criteria
- Brugada Type 2 or 3 syndrome
- Contraindication to electrophysiological exploration
Trial design
Primary purpose
Allocation
Interventional model
Masking
10 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Philippe CHEVALIER, MD PhD, Pr; Elodie MOREL, CRA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal